127 related articles for article (PubMed ID: 2976770)
1. Simultaneous microassay for etretinate and its active metabolite, etretin, by reversed-phase high-performance liquid chromatography.
Thongnopnua P; Zimmerman CL
J Chromatogr; 1988 Dec; 433():345-51. PubMed ID: 2976770
[No Abstract] [Full Text] [Related]
2. Simultaneous determination of the aromatic retinoids etretin and etretinate and their main metabolites by reversed-phase liquid chromatography.
Jakobsen P; Larsen FG; Larsen CG
J Chromatogr; 1987 Apr; 415(2):413-8. PubMed ID: 2953748
[No Abstract] [Full Text] [Related]
3. High-performance liquid chromatography of Ro 10-9359 (tigason) and its metabolite Ro 10-1670 in human plasma.
Besner JG; Meloche S; Leclaire R; Band P; Mailhot S
J Chromatogr; 1982 Sep; 231(2):467-72. PubMed ID: 6215418
[No Abstract] [Full Text] [Related]
4. Simultaneous determination of etretinate, acitretin and their metabolites in perfusate, perfusate plasma, bile or hepatic tissue with reversed-phase high-performance liquid chromatography.
Decker MA; Zimmerman CL
J Chromatogr B Biomed Appl; 1995 May; 667(1):105-13. PubMed ID: 7663673
[TBL] [Abstract][Full Text] [Related]
5. High-performance liquid chromatographic determination of etretinate and all-trans- and 13-cis-acitretin in human plasma.
De Leenheer AP; Lambert WE; De Bersaques JP; Kint AH
J Chromatogr; 1990 Feb; 500():637-42. PubMed ID: 2139439
[TBL] [Abstract][Full Text] [Related]
6. Determination of plasma levels of two aromatic retinoic acid analogues with antipsoriatic activity by high-performance liquid chromatography.
Palmskog G
J Chromatogr; 1980 Dec; 221(2):345-51. PubMed ID: 6452462
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of retinoids in biological fluids by high-performance liquid chromatography using column switching. II. Simultaneous determination of etretinate, acitretin and 13-cis-acitretin in plasma.
Wyss R; Bucheli F
J Chromatogr; 1988 Oct; 431(2):297-307. PubMed ID: 2977389
[TBL] [Abstract][Full Text] [Related]
8. Biotransformation of etretinate and developmental toxicity of etretin and other aromatic retinoids in teratogenesis bioassays.
Kochhar DM; Penner JD; Minutella LM
Drug Metab Dispos; 1989; 17(6):618-24. PubMed ID: 2575497
[TBL] [Abstract][Full Text] [Related]
9. Influence of etretinate on blood and liver in rats.
Sakamoto K; Kasahara T; Nakayama S; Nakai Y; Kudo J
Jpn J Pharmacol; 1982 Dec; 32(6):1175-8. PubMed ID: 7161968
[No Abstract] [Full Text] [Related]
10. Plasma and suction blister fluid levels of etretinate and its main metabolite during treatment of psoriasis.
Lauharanta J; Paravicini U
Arch Dermatol Res; 1982; 272(1-2):147-9. PubMed ID: 6219628
[No Abstract] [Full Text] [Related]
11. In vitro interactions of the aromatic retinoids Ro 10-9359 (etretinate) and Ro 10-1670 (acitretin), its main metabolite, with human serum lipoproteins and albumin.
Carillet V; Morlière P; Mazière JC; Hüppe G; Santus R; Dubertret L
Biochim Biophys Acta; 1990 Nov; 1055(2):98-101. PubMed ID: 2146977
[TBL] [Abstract][Full Text] [Related]
12. Determination of an aromatic retinoid and its main metabolite by high-performance liquid chromatography.
Hänni R; Hervouet D; Busslinger A
J Chromatogr; 1979 Apr; 162(4):615-21. PubMed ID: 528672
[No Abstract] [Full Text] [Related]
13. UV-induced isomerization of oral retinoids in vitro and in vivo in hairless mice.
Berne B; Rollman O; Vahlquist A
Photodermatol Photoimmunol Photomed; 1990 Aug; 7(4):146-52. PubMed ID: 2150173
[TBL] [Abstract][Full Text] [Related]
14. A newly discovered xenobiotic metabolic pathway: ethyl ester formation.
Chou RC; Wyss R; Huselton CA; Wiegand UW
Life Sci; 1991; 49(21):PL169-72. PubMed ID: 1834900
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of Etretinate (Ro 10-9359) and its metabolite (Ro 10-1670).
Ishizaki H; Masuda H; Kaseda H; Kaminaga T; Hirone T
J Dermatol; 1983 Oct; 10(5):421-6. PubMed ID: 6230381
[No Abstract] [Full Text] [Related]
16. Transplacental pharmacokinetics of teratogenic doses of etretinate and other aromatic retinoids in mice.
Reiners J; Löfberg B; Kraft JC; Kochhar DM; Nau H
Reprod Toxicol; 1988; 2(1):19-29. PubMed ID: 2980988
[TBL] [Abstract][Full Text] [Related]
17. Single dose pharmacokinetics of etretin and etretinate in psoriatic patients.
Larsen FG; Jakobsen P; Larsen CG; Nørgaard A; Kragballe K; Nielsen-Kudsk F
Pharmacol Toxicol; 1987 Aug; 61(2):85-8. PubMed ID: 2959917
[TBL] [Abstract][Full Text] [Related]
18. Tissue distribution of aromatic retinoid (etretinate) in three autopsy cases: drug accumulation in adrenals and fat.
Vahlquist A; Rollman O; Pihl-Lundin I
Acta Derm Venereol; 1986; 66(5):431-4. PubMed ID: 2431582
[TBL] [Abstract][Full Text] [Related]
19. Teratogenicity of steady-state concentrations of etretinate and metabolite acitretin maintained in maternal plasma and embryo by intragastric infusion during organogenesis in the mouse: a possible model for the extended elimination phase in human therapy.
Löfberg B; Reiners J; Spielmann H; Nau H
Dev Pharmacol Ther; 1990; 15(1):45-51. PubMed ID: 2147001
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of etretin and etretinate during long-term treatment of psoriasis patients.
Larsen FG; Jakobsen P; Larsen CG; Kragballe K; Nielsen-Kudsk F
Pharmacol Toxicol; 1988 Mar; 62(3):159-65. PubMed ID: 2967472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
